MedPath
FDA Approval

MECLIZINE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 8, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Meclizine(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

St. Mary's Medical Park Pharmacy

St. Mary's Medical Park Pharmacy

063050751

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MECLIZINE HYDROCHLORIDE

Product Details

NDC Product Code
60760-087
Application Number
ANDA040659
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 8, 2022
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
MeclizineActive
Code: HDP7W44CIOClass: ACTIBQuantity: 25 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
© Copyright 2025. All Rights Reserved by MedPath